United Kingdom

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

24 Nov 2017
Change (% chg)

¥-130 (-2.29%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Wed, Nov 8 2017

BRIEF-Kaken Pharmaceutical signs exclusive distribution agreement for Clenafin/Jublia in Taiwan

* Says co signed an exclusive distribution agreement with Tai Tien Pharmaceuticals Co Ltd (Tai Tien), which is a subsidiary of Mitsubishi Tanabe Pharma Corporation, for the topical formulation for Onychomycosis "Clenafin/Jublia" (product) in Taiwan

BRIEF- Kaken Pharmaceutical to begin sale of Jublia in Korea

* Says its partner company Dong-A ST Co., Ltd. will begin the sale of Jublia, a topical formulation drug for Onychomycosis, in Korea, from June 1

Select another date: